AARTIPHARM — Aarti Pharmalabs Balance Sheet
0.000.00%
- IN₹66.63bn
- IN₹69.45bn
- IN₹18.53bn
- 54
- 20
- 83
- 54
Annual balance sheet for Aarti Pharmalabs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | Interim Report | Interim Report | ARS | ARS |
Standards: | — | — | IAS | IAS |
Status: | Final | Final | Final | Final |
Cash | ||||
Cash and Equivalents | ||||
Short Term Investments | ||||
Cash and Short Term Investments | 2.5 | 1,603 | 990 | 1,007 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 0 | 3,882 | 4,524 | 5,893 |
Total Inventory | ||||
Prepaid Expenses | ||||
Total Other Current Assets | ||||
Total Current Assets | 2.5 | 10,281 | 11,558 | 13,456 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | 0 | 9,453 | 9,861 | 10,932 |
Net Goodwill | ||||
Net Intangible Assets | ||||
Long Term Investments | ||||
Long Term Notes Receivable | ||||
Other Long Term Assets | ||||
Total Assets | 2.5 | 20,399 | 22,309 | 25,821 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Current Portion of Long Term Debt / Capital Leases | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 0.219 | 5,807 | 5,916 | 6,944 |
Long Term Debt | ||||
Capital Lease Obligations | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Deferred Income Tax | ||||
Total Other Liabilities | ||||
Total Funded Status | ||||
Total Liabilities | 0.219 | 6,534 | 6,724 | 8,251 |
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Other Equity | ||||
Total Equity | 2.28 | 13,865 | 15,585 | 17,570 |
Total Liabilities & Shareholders' Equity | 2.5 | 20,399 | 22,309 | 25,821 |
Total Common Shares Outstanding |